These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38622555)

  • 1. Prognostic value of pre-treatment [
    Dong Z; Wang GY; Dai DY; Qin GJ; Tang LL; Xu C; Ma J
    BMC Cancer; 2024 Apr; 24(1):466. PubMed ID: 38622555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Head and neck MRI-based T stage and [
    Xie HJ; Sun XS; Zhang X; Xiao BB; Lin DF; Lin XP; Lv XF; Liu LZ; Han F; Zou RH; Li JB; Fan W; Chen QY; Mai HQ; Tang LQ
    Eur Radiol; 2023 Nov; 33(11):7952-7966. PubMed ID: 37314471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival effect of pretreatment FDG-PET-CT on nasopharyngeal cancer.
    Yang PC; Chen WM; Chen M; Shia BC; Wu SY; Chiang CW
    J Formos Med Assoc; 2023 Jan; 122(1):36-46. PubMed ID: 35999158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of outcomes in patients with local recurrent nasopharyngeal carcinoma: development and validation of a four-factor prognostic model integrating baseline characteristics and [
    Dongxiang W; Liting L; Yujing L; Meijuan L; Shanshan G; Longbin X; Yanzhou C; Meiling C; Kang N; Haiqiang M; Linquan T; Qiuyan C
    Eur Radiol; 2023 Apr; 33(4):2840-2849. PubMed ID: 36422647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of baseline [18F]-fluorodeoxyglucose positron emission tomography parameters MTV, TLG and asphericity in an international multicenter cohort of nasopharyngeal carcinoma patients.
    Zschaeck S; Li Y; Lin Q; Beck M; Amthauer H; Bauersachs L; Hajiyianni M; Rogasch J; Ehrhardt VH; Kalinauskaite G; Weingärtner J; Hartmann V; van den Hoff J; Budach V; Stromberger C; Hofheinz F
    PLoS One; 2020; 15(7):e0236841. PubMed ID: 32730364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low value of whole-body dual-modality [18f]fluorodeoxyglucose positron emission tomography/computed tomography in primary staging of stage I-II nasopharyngeal carcinoma: a nest case-control study.
    Xiao BB; Chen QY; Sun XS; Li JB; Luo DH; Sun R; Lin DF; Zhang X; Fan W; Lv XF; Han LJ; Wen YF; Yuan L; Guo SS; Liu LT; Liu SL; Tang QN; Liang YJ; Li XY; Lin C; Guo L; Mai HQ; Tang LQ
    Eur Radiol; 2021 Jul; 31(7):5222-5233. PubMed ID: 33416977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretreatment [
    Gihbid A; Cherkaoui Salhi G; El Alami I; Belgadir H; Tawfiq N; Bendahou K; El Mzibri M; Cadi R; El Benna N; Guensi A; Khyatti M
    Ann Nucl Med; 2022 Oct; 36(10):876-886. PubMed ID: 35836088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benefit of [
    OuYang PY; Liu ZQ; Lin QG; He Y; Guo ZX; Yao WY; Xu SK; Peng QH; Xiao SM; Li J; Li A; Zhang BY; Yang SS; Fan W; Xie CM; Wu YS; Zhang X; Chen CY; Xie FY
    Eur J Nucl Med Mol Imaging; 2023 Feb; 50(3):881-891. PubMed ID: 36301324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive significance of pretreatment
    El-Hennawy G; ElMenawi S; Nasr Said E; Zekri W; Zaghloul M; Elsalam AMA; El-Fendy H; Elantably I
    Pediatr Blood Cancer; 2024 Jul; 71(7):e30998. PubMed ID: 38650170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential roles of 18F-FDG PET in patients with locoregional advanced nasopharyngeal carcinoma after primary curative therapy: response evaluation and impact on management.
    Chan SC; Yen TC; Ng SH; Lin CY; Wang HM; Liao CT; Fan KH; Chang JT
    J Nucl Med; 2006 Sep; 47(9):1447-54. PubMed ID: 16954552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selectively recommend
    Chen C; Xu T; Qiu X; Xie S; You Z; Hu Y; Zheng Y; Liang Z; Huang C; Chen T; Li L; Liu J; Fei Z
    Radiat Oncol; 2021 Nov; 16(1):229. PubMed ID: 34838075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PET/CT standardized uptake value and EGFR expression predicts treatment failure in nasopharyngeal carcinoma.
    Fei Z; Xu T; Hong H; Xu Y; Chen J; Qiu X; Ding J; Huang C; Li L; Liu J; Chen C
    Radiat Oncol; 2023 Feb; 18(1):33. PubMed ID: 36814303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical utility of [
    Zhao L; Pang Y; Zheng H; Han C; Gu J; Sun L; Wu H; Wu S; Lin Q; Chen H
    Eur J Nucl Med Mol Imaging; 2021 Oct; 48(11):3606-3617. PubMed ID: 33792760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of the post-radiotherapy
    Jeong Y; Jung IH; Kim JS; Chang SK; Lee SW
    Br J Radiol; 2019 Oct; 92(1102):20180045. PubMed ID: 30102562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Clinical Usefulness of (18)F-Fluorodeoxyglucose Positron Emission Tomography (PET) to Predict Oncologic Outcomes and PET-Based Radiotherapeutic Considerations in Locally Advanced Nasopharyngeal Carcinoma.
    Yoon HI; Kim KH; Lee J; Roh YH; Yun M; Cho BC; Lee CG; Keum KC
    Cancer Res Treat; 2016 Jul; 48(3):928-41. PubMed ID: 26693913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of early evaluation of treatment response using
    Chen YH; Chang KP; Chu SC; Yen TC; Wang LY; Chang JT; Hsu CL; Ng SH; Liu SH; Chan SC
    Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):650-660. PubMed ID: 30264225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of 18F-FDG PET in the detection of stage M0 carcinoma of the nasopharynx.
    Yen TC; Chang JT; Ng SH; Chang YC; Chan SC; Lin KJ; Lin WJ; Fu YK; Lin CY
    J Nucl Med; 2005 Mar; 46(3):405-10. PubMed ID: 15750151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different prognostic values of plasma Epstein-Barr virus DNA and maximal standardized uptake value of 18F-FDG PET/CT for nasopharyngeal carcinoma patients with recurrence.
    Shen T; Tang LQ; Luo DH; Chen QY; Li PJ; Mai DM; Guo SS; Liu LT; Qian CN; Guo X; Zeng MS; Mo HY; Mai HQ
    PLoS One; 2015; 10(4):e0122756. PubMed ID: 25853677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic and prognostic value of 18F-FDG PET/CT in recurrent germinal tumor carcinoma.
    Alongi P; Evangelista L; Caobelli F; Spallino M; Gianolli L; Midiri M; Picchio M
    Eur J Nucl Med Mol Imaging; 2018 Jan; 45(1):85-94. PubMed ID: 28828589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole-body
    Ren YY; Li YC; Wu HB; Wang QS; Han YJ; Zhou WL; Li HS
    Eur J Radiol; 2017 Apr; 89():200-207. PubMed ID: 28267540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.